GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D. Western Therapeutics Institute Inc (TSE:4576) » Definitions » Gross-Profit-to-Asset %

D. Western Therapeutics Institute (TSE:4576) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is D. Western Therapeutics Institute Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. D. Western Therapeutics Institute's annualized Gross Profit for the quarter that ended in Dec. 2024 was 円0.0 Mil. D. Western Therapeutics Institute's average Total Assets over the quarter that ended in Dec. 2024 was 円1,867.5 Mil. Therefore, D. Western Therapeutics Institute's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 0.00%.


D. Western Therapeutics Institute Gross-Profit-to-Asset % Historical Data

The historical data trend for D. Western Therapeutics Institute's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D. Western Therapeutics Institute Gross-Profit-to-Asset % Chart

D. Western Therapeutics Institute Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.35 15.16 15.52 14.70 21.01

D. Western Therapeutics Institute Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.63 16.87 17.05 20.90 -

Competitive Comparison of D. Western Therapeutics Institute's Gross-Profit-to-Asset %

For the Biotechnology subindustry, D. Western Therapeutics Institute's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


D. Western Therapeutics Institute's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D. Western Therapeutics Institute's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where D. Western Therapeutics Institute's Gross-Profit-to-Asset % falls into.


;
;

D. Western Therapeutics Institute Gross-Profit-to-Asset % Calculation

D. Western Therapeutics Institute's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=424.736/( (2373.371+1669.444)/ 2 )
=424.736/2021.4075
=21.01 %

D. Western Therapeutics Institute's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (2065.605+1669.444)/ 2 )
=0/1867.5245
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


D. Western Therapeutics Institute Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of D. Western Therapeutics Institute's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


D. Western Therapeutics Institute Business Description

Traded in Other Exchanges
N/A
Address
7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.

D. Western Therapeutics Institute Headlines

No Headlines